Atlas Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Hold |
268
| – | – | ﹤0.01% | 720 |
|
|
2025
Q1 | $18.6K | Sell |
268
-5,704
| -96% | -$396K | ﹤0.01% | 744 |
|
|
2024
Q4 | $514K | Sell |
5,972
-468
| -7% | -$40.3K | 0.07% | 230 |
|
|
2024
Q3 | $767K | Sell |
6,440
-70
| -1% | -$8.34K | 0.12% | 157 |
|
|
2024
Q2 | $929K | Sell |
6,510
-1,682
| -21% | -$240K | 0.12% | 137 |
|
|
2024
Q1 | $1.05M | Sell |
8,192
-1,000
| -11% | -$128K | 0.16% | 115 |
|
|
2023
Q4 | $951K | Buy |
9,192
+883
| +11% | +$91.3K | 0.14% | 127 |
|
|
2023
Q3 | $756K | Sell |
8,309
-201
| -2% | -$18.3K | 0.12% | 130 |
|
|
2023
Q2 | $689K | Hold |
8,510
| – | – | 0.1% | 150 |
|
|
2023
Q1 | $677K | Sell |
8,510
-68
| -0.8% | -$5.41K | 0.11% | 146 |
|
|
2022
Q4 | $580K | Sell |
8,578
-4,528
| -35% | -$306K | 0.1% | 165 |
|
|
2022
Q3 | $653K | Sell |
13,106
-992
| -7% | -$49.4K | 0.12% | 140 |
|
|
2022
Q2 | $785K | Sell |
14,098
-1,452
| -9% | -$80.9K | 0.13% | 131 |
|
|
2022
Q1 | $863K | Buy |
15,550
+382
| +3% | +$21.2K | 0.13% | 136 |
|
|
2021
Q4 | $849K | Buy |
15,168
+4,552
| +43% | +$255K | 0.13% | 135 |
|
|
2021
Q3 | $510K | Buy |
+10,616
| New | +$510K | 0.08% | 199 |
|
|
2018
Q4 | – | Sell |
-11,866
| Closed | -$277K | – | 589 |
|
|
2018
Q3 | $277K | Sell |
11,866
-8,834
| -43% | -$206K | 0.09% | 251 |
|
|
2018
Q2 | $519K | Sell |
20,700
-26,684
| -56% | -$669K | 0.18% | 152 |
|
|
2018
Q1 | $1.17M | Buy |
+47,384
| New | +$1.17M | 0.36% | 82 |
|